NCT01828762View on ClinicalTrials.gov

Autologous Immune Cell Therapy in Primary Hepatocellular Carcinoma Patients Following Resection and TACE Therapy

NACompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

December 31, 2013

Conditions
Primary Hepatocellular Carcinoma
Interventions
BIOLOGICAL

DC-TC+GM-CSF

Trial Locations (1)

200235

9585 Humin Road,Xuhui district, Shanghai

Sponsors
All Listed Sponsors
collaborator

No.85 Hospital, Changning, Shanghai, China

OTHER

collaborator

China Cell Technology Ltd.

OTHER

lead

Shanghai AbelZeta Ltd.

INDUSTRY